Ajanta Pharma USA Inc recalls
Every recall we track for Ajanta Pharma USA Inc — 4 in all, all from 2026 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
4 recalls since 2017.
All FDA recall records for Ajanta Pharma USA Inc since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 1 | 2 | 1 | 4 |
What to do if you have a recalled Ajanta Pharma USA Inc product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Ajanta Pharma USA Inc recalls
4 shown- Use cautionDrug
Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma USA Inc. recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottles due to failed dissolution specifications.
Ajanta PharmaSep 17, 2026 - Lower riskDrug
Ajanta Pharma USA Inc recalls Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma recalls 100-count Fluphenazine Hydrochloride tablets due to impurity levels exceeding safety limits. Affected lots have specific expiration dates and are prescription-only.
Ajanta PharmaAug 25, 2026 - UnratedDrug
Ajanta Pharma USA Inc recalls Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by:
Ajanta Pharma USA recalls 200mg Fenofibrate capsules due to CGMP deviations. Consumers should check NDC 27241-120-04 and lot # PA02216 for affected units.
Ajanta PharmaMay 28, 2026 - Lower riskDrug
Ajanta Pharma USA Inc recalls Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made
Ajanta Pharma recalls 30mg Aripiprazole tablets due to mix-up with Voriconazole tablets. This could lead to incorrect medication use. Check your NDC 27241-056-03 lot PA00805.
Ajanta PharmaMay 27, 2026
Ajanta Pharma USA Inc recall questions
How many recalls has Ajanta Pharma USA Inc had?
4 recalls from Ajanta Pharma USA Inc are on record with U.S. safety agencies, from 2026.
What is the most recent Ajanta Pharma USA Inc recall?
Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,, dated Sep 17, 2026. Every Ajanta Pharma USA Inc recall is listed on this page, newest first.
What should I do if I have a recalled Ajanta Pharma USA Inc product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Ajanta Pharma USA Inc recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.